NEUROONE MEDICAL TECHNOLOGIES Corp
NMTC· Nasdaq
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Source filing unavailable
| Metric | Q4 2021 | Q4 2020 | Q4 2019dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | $33.75K | $71.47K | — | — |
| Net Income | -$2.81M | -$1.96M | -$1.35M | -$2.09M |
| EPS Diluted | -$0.18 | -$0.26 | — | — |
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
